Clinical Trial Update: Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial at Cairo University evaluating allogeneic bone marrow–derived mesenchymal stem cell therapy for hemophilia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Allogeneic bone marrow-derived mesenchymal stem cell therapy (mesenchymal stem cells (allogeneic, bone marrow-derived))

Snippet

Sponsor: Cairo University | Conditions: Hemophilia | Phase 1 | Status: UNKNOWN